Effect of Evolocumab on Chronic Total Occlusions (EVOLO-CTO)

Clinical trial NCT05623995 · UNKNOWN

Trial details

NCT number: NCT05623995
Sponsor: Lin Zhao
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

In-stent Restenosis Major Adverse Cardiovascular Events

Start date: 2022-12-15
Primary completion: 2024-12-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.